Amirhosein Kefayat | Pharmaceutical Chemistry | Top Pharmaceutical Scientist Award

Published on by Top Pharmaceutical

Dr. Amirhosein Kefayat | Pharmaceutical Chemistry | Top Pharmaceutical Scientist Award

Edinburgh of University | United Kingdom

Dr. Amirhosein Kefayat is a distinguished physician-scientist specializing in oncology, nanomedicine, cancer immunotherapy, and radiation oncology, with extensive experience in translational research and clinical studies. He earned his Doctorate of Medicine (MD) from Isfahan University of Medical Sciences in 2019 and has since advanced his qualifications with multiple prestigious certifications, including full registration with the General Medical Council (UK) and ongoing ECFMG certification for the United States.Currently serving as a Clinical Research Fellow at the Institute of Genetics & Cancer, University of Edinburgh & NHS Lothian (UK), Dr. Kefayat contributes to UK-wide clinical trials such as ACESO, BIOPIC, DEFINE, PROFILE, PAN-IBD, and Gut Cell Atlas. He also leads systematic review and meta-analysis teams, influencing major clinical guidelines like the British Society of Gastroenterology 2024 update.Previously, as a Clinical Research Fellow at the Dept. of Radiotherapy & Oncology, Arak University of Medical Sciences (Iran), he led multiple high-impact research projects, resulting in numerous publications, international conference presentations, patents, and national research grants (INSF, NIMAD).Dr. Kefayat has published extensively in top Q1 journals such as Carbohydrate Polymers, Biosensors & Bioelectronics, Vaccine, Scientific Reports, Journal of Biomolecular Structure & Dynamics, and Nanomedicine. His work on novel cancer vaccines, wound healing biomaterials, and radiosensitizers ranks among the top 1–10% most-cited papers worldwide, reflecting his global research impact.His notable accolades include recognition as the top 0.5% of scholars worldwide (2024), membership in Iran’s National Elites Foundation, and multiple national research grants. His patented biomaterial for diabetic wound healing demonstrates his commitment to bridging laboratory research with clinical application.

Profile: Google Scholar

Featured Publications

Eskandarinia, A., Kefayat, A., Agheb, M., Rafienia, M., & Amini Baghbadorani, M. (2020). A novel bilayer wound dressing composed of a dense polyurethane/propolis membrane and a biodegradable polycaprolactone/gelatin nanofibrous scaffold. Scientific Reports, 10(1), 3063.

Eskandarinia, A., Kefayat, A., Gharakhloo, M., Agheb, M., Khodabakhshi, D., Rafienia, M., & Navid, S. (2020). A propolis enriched polyurethane-hyaluronic acid nanofibrous wound dressing with remarkable antibacterial and wound healing activities. International Journal of Biological Macromolecules, 149, 467–476.

Safavi, A., Kefayat, A., Mahdevar, E., Abiri, A., & Ghahremani, F. (2020). Exploring the out of sight antigens of SARS-CoV-2 to design a candidate multi-epitope vaccine by utilizing immunoinformatics approaches. Vaccine, 38(48), 7612–7628.

Khodabakhshi, D., Eskandarinia, A., Kefayat, A., Rafienia, M., Navid, S., & Agheb, M. (2019). In vitro and in vivo performance of a propolis-coated polyurethane wound dressing with high porosity and antibacterial efficacy. Colloids and Surfaces B: Biointerfaces, 178, 177–184.

Eskandarinia, A., Kefayat, A., Rafienia, M., Agheb, M., Navid, S., & Ebrahimpour, K. (2019). Cornstarch-based wound dressing incorporated with hyaluronic acid and propolis: In vitro and in vivo studies. Carbohydrate Polymers, 216, 25–35.

Karizmeh, M. S., Poursamar, S. A., Kefayat, A., Farahbakhsh, Z., & Rafienia, M. (2022). An in vitro and in vivo study of PCL/chitosan electrospun mat on polyurethane/propolis foam as a bilayer wound dressing. Biomaterials Advances, 135, 112667.

Ghahremani, F., Shahbazi-Gahrouei, D., Kefayat, A., Motaghi, H., & Amouheidari, A. (2018). AS1411 aptamer conjugated gold nanoclusters as a targeted radiosensitizer for megavoltage radiation therapy of 4T1 breast cancer cells. RSC Advances, 8(8), 4249–4258.

Safavi, A., Kefayat, A., Abiri, A., Mahdevar, E., Behnia, A. H., & Ghahremani, F. (2019). In silico analysis of transmembrane protein 31 (TMEM31) antigen to design novel multiepitope peptide and DNA cancer vaccines against melanoma. Molecular Immunology, 112, 93–102.

Krishna Pada Das | Bioinformatics in Pharmaceuticals | Best Researcher Award

Published on by Top Pharmaceutical

Assoc. Prof. Dr. Krishna Pada Das | Bioinformatics in Pharmaceuticals | Best Researcher Award

Mahadevananda Mahavidyalaya | India

Assoc. Prof. Dr. Krishna Pada Das is a distinguished academic with a robust background in mathematical biology, particularly in the field of population dynamics and mathematical modeling. He obtained his Bachelor’s and Master’s degrees in Mathematical Science from Calcutta University, Kolkata, before completing his Ph.D. in Applied Mathematics at Jadavpur University, Kolkata, under the guidance of Prof. Joydev Chattopadhyay of the Indian Statistical Institute. His doctoral research, which focused on the nonlinear dynamics of predator-prey interactions with disease in the population, laid the foundation for his continued work in mathematical modeling of ecological and epidemiological systems.Dr. Das has held various academic positions throughout his career, starting as a Junior Research Fellow at the Indian Statistical Institute in the Agricultural and Ecological Research Unit, where he worked from 2006 to 2008. He was later promoted to Senior Research Fellow until 2010. His academic career at Mahadevananda Mahavidyalaya, Kolkata, began in 2010, where he served as an Assistant Professor and was later promoted to Associate Professor in 2022. His academic positions have allowed him to make significant contributions to both research and teaching in the field of applied mathematics, especially in mathematical ecology and epidemiology.His primary research interests lie in mathematical modeling for biological systems, with a particular focus on the dynamics of populations in ecological and epidemiological settings. His work spans a variety of complex systems, including predator-prey models, disease transmission dynamics, plankton population dynamics, and eco-epidemiology. Dr. Das uses advanced mathematical techniques, including ordinary differential equations, stochastic processes, delay differential equations, and fractional calculus, to model the behavior of these systems. His current research explores HIV infection models, epidemiological models, and eco-epidemiological systems, with an emphasis on understanding the effects of factors such as time delays, diffusion, spatio-temporal dynamics, and the role of randomness in these systems.

Profile: Google Scholar

Featured Publications

Das, K., & Mukherjee, A. K. (2007). Differential utilization of pyrene as the sole source of carbon by Bacillus subtilis and Pseudomonas aeruginosa strains: Role of biosurfactants in enhancing. Journal of Applied Microbiology, 102(1), 195-203.

Soni, B. K., Das, K., & Ghose, T. K. (1982). Bioconversion of agro-wastes into acetone butanol. Biotechnology Letters, 4(1), 19-22.

Dutta, S. K., Das, K., Ghosh, B., & Blackman, C. F. (1992). Dose dependence of acetylcholinesterase activity in neuroblastoma cells exposed to modulated radio-frequency electromagnetic radiation. Bioelectromagnetics, 13(4), 317-322.

Kooi, B. W., van Voorn, G. A. K., & Das, K. P. (2011). Stabilization and complex dynamics in a predator–prey model with predator suffering from an infectious disease. Ecological Complexity, 8(1), 113-122.

Das, C. R., Mondal, N. K., Aditya, P., Datta, J. K., Banerjee, A., & Das, K. (2012). Allelopathic potentialities of leachates of leaf litter of some selected tree species on gram seeds under laboratory conditions. Asian Journal of Experimental Biological Sciences, 3(1), 59-65.

Das, K. P., Kundu, K., & Chattopadhyay, J. (2011). A predator–prey mathematical model with both the populations affected by diseases. Ecological Complexity, 8(1), 68-80.

Ghose, T. K., & Das, K. (2006). A simplified kinetic approach to cellulose-cellulase system. Advances in Biochemical Engineering, 1, 55-76.

Das, A., Ghosh, S., Das, K., Basu, T., Das, M., & Dutta, I. (2020). Modeling the effect of area deprivation on COVID-19 incidences: A study of Chennai megacity, India. Public Health, 185, 266-269.

Shadi Hamoud | Clinical Trials | Excellence in Research Award

Published on by Top Pharmaceutical

Dr. Shadi Hamoud | Clinical Trials | Excellence in Research Award

Rambam health care campus | Israel

Dr. Shadi Hamoud is a distinguished physician, clinical researcher, and academic leader whose career spans internal medicine, cardiovascular research, and translational medicine. Earning his medical degree with honors from the Faculty of Medicine at the Hebrew University in Jerusalem, Dr. Hamoud embarked on a professional journey characterized by clinical excellence, research innovation, and a deep commitment to medical education. Over the years, he has combined patient-centered care with groundbreaking research, focusing on lipoprotein oxidation, atherosclerosis, the role of the enzyme heparanase in kidney injury, fatty liver disease, and cardiovascular disorders, as well as pioneering clinical trials for novel oral anticoagulants, lipid-modifying agents, diabetes treatments, and therapies for emerging infectious diseases such as COVID-19.As Deputy Director of the Department of Internal Medicine E at Rambam Medical Center and Director of the Clinical Research Unit, Dr. Hamoud has overseen numerous national and international clinical studies, collaborating with leading pharmaceutical companies, including Bayer, Pfizer, Novartis, Sanofi, and AstraZeneca. His research portfolio reflects expertise in designing and conducting complex multicenter clinical trials addressing some of the most challenging issues in cardiovascular medicine and metabolic diseases. Additionally, his clinical consultancy roles across multiple departments at Rambam Health Care Campus highlight his interdisciplinary approach to medicine, ensuring that research findings translate effectively into improved patient outcomes.An accomplished educator, Dr. Hamoud has dedicated decades to training the next generation of physicians, serving as a clinical lecturer at the Technion-Israel Institute of Technology and mentoring medical students, interns, and graduate researchers. Under his supervision, numerous MD and basic science theses have been completed, exploring critical areas such as oxidative stress, endothelial dysfunction, liver steatosis, and the molecular pathways of atherosclerosis. His leadership as Program Director for the Internal Medicine Preparatory Course for National Licensing Examinations further reflects his commitment to academic excellence and medical training standards.

Profile: Orcid

Featured Publications

Hamoud, S., Hacker, I., Karram, T., Fokra, A., Kabala, A., & Abassi, Z. (2024). Gender-specific renoprotective pathways in αMUPA transgenic mice subjected to acute kidney injury. International Journal of Molecular Sciences.

Cohen-Segev, R., Nativ, O., Kinaneh, S., Aronson, D., Kabala, A., Hamoud, S., Karram, T., & Abassi, Z. (2023). Effects of angiotensin 1-7 and Mas receptor agonist on renal system in a rat model of heart failure. International Journal of Molecular Sciences.

Kinaneh, S., Hijaze, W., Mansour-Wattad, L., Hammoud, R., Zaidani, H., Kabala, A., & Hamoud, S. (2022). Heparanase inhibition prevents liver steatosis in E₀ mice. Journal of Clinical Medicine.

[Author names not fully provided]. (n.d.). Predictors of survival in subjects treated in the “shock room” of the emergency department in a tertiary medical center.

Xiangxuan Zhao | Drug Discovery and Development | Best Researcher Award

Published on by Top Pharmaceutical

Prof. Xiangxuan Zhao | Drug Discovery and Development | Best Researcher Award

Liaoning University of Traditional Chinese Medicine | China

Prof. Xiangxuan Zhao is a distinguished cell biologist and an eminent academic leader renowned for his pioneering contributions to the field of natural medicine-derived anti-cancer therapeutics. Serving as Professor, Doctoral Supervisor, and Postdoctoral Mentor, he holds prestigious positions as the Dean of the College of Laboratory Animal Medicine and Director of the Laboratory Animal Center at the Liaoning University of Traditional Chinese Medicine in Shenyang, China. With a career dedicated to advancing the frontiers of cancer biology and pharmaceutical innovation, Prof. Zhao has established himself as a leading authority in tumor drug resistance mechanisms, molecular target discovery, molecular targeted drug development, and tumor immunotherapy research.Prof. Zhao’s academic journey reflects a blend of scientific rigor and innovative leadership. Prior to his current roles, he contributed significantly as Deputy Director of the Engineering Technology Center for TCM Innovation at Liaoning University of Traditional Chinese Medicine and as a Researcher at the Health Science Research Institute of China Medical University. His earlier tenure as an Associate Researcher at Shengjing Hospital, China Medical University, laid the groundwork for his expertise in translational medicine, fostering a seamless bridge between laboratory research and clinical applications.A prolific scholar, Prof. Zhao has authored and co-authored eighty-four academic papers, including thirty-one SCI-indexed publications with a cumulative impact factor of one hundred eighty-eight. Among these, five papers boast impact factors exceeding ten, with his highest-impact publication reaching an impressive twenty-seven point four. His scientific excellence is further reflected in the thirteen national patents he holds, with four as the first inventor, underscoring his role as a trailblazer in molecular oncology and therapeutic innovation.

Profile: Orcid

Featured Publications

Liu, Y., Guo, R., Xue, C., Zhang, X., Xiao, F., Zhao, X., Zhu, Z., & Li, K. (2025). Phytosphingosine suppresses gastric cancer through SFRP4/β-catenin axis-mediated Wnt signaling pathway inhibition. Chemico-Biological Interactions.

Ke, W., Wang, H., Zhao, X., & Lu, Z. (2021). Foeniculum vulgare seed extract exerts anti-cancer effects on hepatocellular carcinoma. Food & Function.

Sun, W., Ren, Y., Lu, Z., & Zhao, X. (2020). The potential roles of exosomes in pancreatic cancer initiation and metastasis. Molecular Cancer.

Ke, W., Zhao, X., & Lu, Z. (2020). Bcl-2 is essential for Foeniculum vulgare seed extract-induced apoptosis in lung cancer. Research Square.

Huachuan Zheng | Pharmacology | Best Innovation Award

Published on by Top Pharmaceutical

Prof. Dr. Huachuan Zheng | Pharmacology | Best Innovation Award

The First Affiliated Hospital of Jinzhou Medical University | China

Prof. Dr. Huachuan Zheng is a distinguished scholar, educator, and research leader whose pioneering work in oncology has significantly advanced the understanding of cancer biology and its clinical applications. With a strong academic foundation that began at China Medical University, where he earned his B.M., M.S., and M.D. degrees, followed by a Ph.D. in Pathology from the University of Toyama in Japan, Prof. Zheng has built a career dedicated to unraveling the molecular mechanisms underlying tumor development and progression. His postdoctoral fellowship at the Kanagawa Cancer Center in Japan further strengthened his expertise in cancer molecular pathology, setting the stage for a prolific academic and research journey.Throughout his career, Prof. Zheng has held several prestigious positions, including serving as the Director of Basic and Translational Cancer Laboratories, Central Laboratories, Experimental Animal Centers, and Cancer Experiment Centers at leading institutions such as the First Affiliated Hospital of Jinzhou Medical University and the Affiliated Hospital of Chengde Medical University. His leadership has extended beyond research to academic administration, where he has contributed as Secretary of the Party Committee and Executive Vice Dean at the Jinzhou Medical University Academy of Life Sciences. Currently, he serves as Director, Professor, and Doctoral Supervisor at the First Affiliated Hospital of Jinzhou Medical University, where he continues to guide innovative cancer research and mentor the next generation of scientists. Prof. Zheng’s research has focused on critical areas such as the molecular mechanisms driving malignant tumor initiation and metastasis, the carcinogenic pathways involving JC virus T antigen, cancer bioinformatics, and the development of spontaneous tumor transgenic animal models. Prof. Zheng leads cutting-edge research on malignant tumor initiation, metastasis, JC virus oncogenesis, cancer bioinformatics, and transgenic animal models. His prolific output includes 212 documents, 5,182 citations, and an h-index of 36, reflecting his global impact on cancer research and precision oncology. His groundbreaking work has not only contributed to the fundamental understanding of cancer biology but has also paved the way for translational applications in early diagnosis, targeted therapy, and personalized treatment approaches for various malignancies, including lung, digestive system, and gynecological cancers.

Profile: Scopus

Featured Publications

Author(s). (2025). RNF180 suppressed aggressiveness by degrading NOTCH1, TRIM24 and FOXC1, and chemoresistance by degrading ACC1 and ACLY in colorectal cancer. International Immunopharmacology.

Author(s). (2025). Effective synthesis of benzodiazepine sulfonamide-based MGAT2 inhibitors and evaluation of their antitumor activity. RSC Advances.

Author(s). (2025). Dkk3 inhibits the aggressiveness and mitigates chemoresistance through low lipid droplet formation in gastric cancer: A biomarker and gene therapy target. International Immunopharmacology.

Author(s). (2025). IFN-γ downregulates miR-4319 to enhance NLRC5 and MHC-I expression in MHC-I-deficient breast cancer cells. Cancer Biology and Therapy.

Author(s). (2025). RNF180 weakened the lipid droplet formation and subsequent chemoresistance by destabilizing ACC1 and ACLY in esophageal cancer. Frontiers in Pharmacology.

Author(s). (2025). Chaetoglobosin A induces apoptosis in T-24 human bladder cancer cells through oxidative stress and MAPK/PI3K-AKTmTOR pathway. PeerJ.

Author(s). (2024). The promoting effects of Grin2d expression in tumorigenesis and the aggressiveness of esophageal cancer. Histology and Histopathology.

Author(s). (2024). The antitumor and sorafenib-resistant reversal effects of ursolic acid on hepatocellular carcinoma via targeting ING5. International Journal of Biological Sciences.

Author(s). (2024). The oncogenic roles of GPR176 in ovarian cancer: A molecular target for aggressiveness and gene therapy. Journal of Obstetrics and Gynaecology.

Ageliki Karatza | Clinical Trials | Best Researcher Award

Published on by Top Pharmaceutical

Prof. Dr. Ageliki Karatza | Clinical Trials | Best Researcher Award

University of Patras Medical School | Greece

Prof. Dr. Ageliki Karatza is a distinguished figure in the field of Paediatrics and Paediatric Cardiology, recognized for her exceptional academic achievements, clinical expertise, and research contributions spanning decades. Her journey began with her admission to the University of Patras Medical School through highly competitive national examinations, where she graduated with one of the top degrees in her class. Following her graduation, she completed her rural medical service before pursuing specialization in General Paediatrics, earning her board certification after extensive training and rigorous examinations.Her dedication to advancing paediatric care led her to prominent institutions in London, including Imperial College, Hammersmith and Queen Charlotte’s Hospitals, and the Royal Brompton Hospital, where she gained substantial clinical and research experience in Paediatric and Perinatal Cardiology. Her fellowship and registrar positions in Neonatal and Paediatric Cardiology enabled her to develop expertise in managing complex cardiovascular conditions in neonates, infants, and children. Upon returning to Greece, she held key positions in academic medicine at the University of Patras Medical School, progressing through roles as Clinical Lecturer, Senior Lecturer, Associate Professor, and ultimately achieving the rank of Professor in Paediatrics-Paediatric Cardiology.In addition to her teaching responsibilities, she has been instrumental in organizing and delivering undergraduate and postgraduate education, serving as a tutor in multiple master’s programs and teaching medical students and trainees at various levels. Her role as the ERASMUS representative in Paediatrics has facilitated international academic collaborations and student exchanges, strengthening the global reach of the University of Patras Medical School. Clinically, she has been responsible for the Paediatric Cardiology outpatient clinic, providing daily consultations and urgent care services for the entire Southwestern Greece region, ensuring that paediatric patients receive timely and specialized cardiac care.

Profile: Google Scholar

Featured Publications

Karatza, A. A., Wolfenden, J. L., Taylor, M. J. O., Wee, L., Fisk, N. M., & Gardiner, H. M. (2002). Influence of twin-twin transfusion syndrome on fetal cardiovascular structure and function: Prospective case–control study of 136 monochorionic twin pregnancies. Heart, 88(3), 271–277.

Karatza, A. A., Bush, A., & Magee, A. G. (2005). Safety and efficacy of sildenafil therapy in children with pulmonary hypertension. International Journal of Cardiology, 100(2), 267–273.

Davlouros, P. A., Karatza, A. A., Gatzoulis, M. A., & Shore, D. F. (2004). Timing and type of surgery for severe pulmonary regurgitation after repair of tetralogy of Fallot. International Journal of Cardiology, 97, 91–101.

Gardiner, H. M., Taylor, M. J. O., Karatza, A., Vanderheyden, T., Huber, A., … (2003). Twin-twin transfusion syndrome: The influence of intrauterine laser photocoagulation on arterial distensibility in childhood. Circulation, 107(14), 1906–1911.

Fouzas, S., Karatza, A. A., Davlouros, P. A., Chrysis, D., Alexopoulos, D., … (2014). Neonatal cardiac dysfunction in intrauterine growth restriction. Pediatric Research, 75(5), 651–657.

Karatza, A. A., Giannakopoulos, I., Dassios, T. G., Belavgenis, G., Mantagos, S. P., … (2011). Periconceptional tobacco smoking and isolated congenital heart defects in the neonatal period. International Journal of Cardiology, 148(3), 295–299.

Tsintoni, A., Dimitriou, G., & Karatza, A. A. (2020). Nutrition of neonates with congenital heart disease: Existing evidence, conflicts, and concerns. The Journal of Maternal-Fetal & Neonatal Medicine, 33(14), 2487–2492.

Anthracopoulos, M., Karatza, A., Liolios, E., Triga, M., Triantou, K., & Priftis, K. (2001). Prevalence of asthma among schoolchildren in Patras, Greece: Three surveys over 20 years. Thorax, 56(7), 569–571.

Beril Anilanmert | Pharmaceutical Analysis | Best Researcher Award

Published on by Top Pharmaceutical

Assoc. Prof. Dr. Beril Anilanmert | Pharmaceutical Analysis | Best Researcher Award

Istanbul University-Cerrahpasa | Turkey

Assoc. Prof. Dr. Beril Anılanmert, a distinguished scholar in forensic and analytical chemistry, has built an exemplary academic and professional career through unwavering dedication to research, teaching, and scientific advancement. She completed her undergraduate, postgraduate, and doctorate studies at Marmara University and Istanbul University, focusing on pharmaceutical sciences, forensic sciences, and analytical chemistry. Over the years, she has contributed extensively to academia through various academic positions, including Associate Professor at Istanbul University-Cerrahpaşa, Institute of Forensic Sciences, where she continues to guide future scientists and lead groundbreaking research projects.Dr. Anılanmert has been the principal investigator and collaborator on numerous funded projects, including the development of advanced LC-MS/MS and HPLC analytical methods for detecting toxic substances, drugs, and explosives in complex matrices. Her work has led to innovative solutions for rapid detection in forensic toxicology, food safety, and environmental chemistry. Notable projects include the development of high-throughput analytical methods for determining substances such as GHB, ketamine, phenobarbital, zolpidem, and various drug metabolites in biological and environmental samples.Her research excellence is reflected in a prolific publication record in high-impact journals indexed in SCI, SSCI, and AHCI. Among her widely cited works are From One Strand Dyed/Undyed Hair With/Without Root to Fast and Successful STR Profiling and Evaluation With Principle Component Analysis, Urgent First-Step Screening Method for Ketamine, Phenobarbital, Zopiclone, Zolpidem, Phenytoin and Thiopental in Adulterated Soft Drink, Speedy Gonzales Analysis Method in One Drop of Beverage, for Crimes Committed With Drugs From Three Different Groups, LC-MS/MS Monitoring for Explosives Residues and OGSR With Diverse Ionization Temperatures in Soil & Hands: 30 Minutes for Extraction Plus Elution, Who Touched the Document?: A New Overall Strategy for Collection and Identification of DNA From the Questioned Documents as a Supportive Evidence, and Fast Chromatographic Screening Method for 7 Drugs of Potential Threat in Drug Facilitated Crimes.

Profile: Orcid

Featured Publications

Anılanmert, B., Cavus Yonar, F., & Acikkol, M. Short-cut route validated for monitoring fentanyl and its metabolite in urine using LC–MS/MS, in a wide concentration range. Future Journal of Pharmaceutical Sciences.

Anılanmert, B., & Cavus Yonar, F. Speedy Gonzales analysis method in one drop of beverage, for crimes committed with drugs from three different groups. Analytical Sciences.

Anılanmert, B. Who touched the document?: A new overall strategy for collection and identification of DNA from the questioned documents as a supportive evidence. Electrophoresis.

Anılanmert, B. LC-MS/MS monitoring for explosives residues and OGSR with diverse ionization temperatures in soil & hands: 30 minutes for extraction + elution. Acta Chromatographica.

Anılanmert, B. A fast method for monitoring of organic explosives in soil: a gas temperature gradient approach in LC–APCI/MS/MS. Chemical Papers.

Anılanmert, B. Rapid and simple analysis of trace levels of three explosives in soil by liquid chromatography—tandem mass spectrometry. Acta Chromatographica.

Anılanmert, B. A Fast Liquid Chromatography Tandem Mass Spectrometric Analysis of PETN (Pentaerythritol Tetranitrate), RDX (3,5-Trinitro-1,3,5-triazacyclohexane) and HMX (Octahydro-1,3,5,7-tetranitro-1,3,5,7-tetrazocine) in Soil, Utilizing a Simple Ultrasonic-Assisted Extraction with Minimum Solvent. Analytical Sciences.

Anılanmert, B. Simultaneous analysis method for GHB, ketamine, norketamine, phenobarbital, thiopental, zolpidem, zopiclone and phenytoin in urine, using C18 poroshell column. Journal of Chromatography B.

Xu Yufen | Drug Discovery and Development | Best Researcher Award

Published on by Top Pharmaceutical

Dr. Xu Yufen | Drug Discovery and Development | Best Researcher Award

The Affiliated Hospital of Jiaxing University | China

Dr. Xu Yufen, Ph.D. in Medicine and Associate Professor at Jiaxing University, has emerged as a dedicated academic and clinical researcher in the field of chest tumors, with a strong focus on lung cancer, esophageal cancer, and thymoma. Her academic and professional journey reflects a unique blend of clinical insight and rigorous scientific research, bridging traditional and modern medical practices to address some of the most pressing challenges in oncology.Her research portfolio encompasses multiple completed and ongoing projects, including significant contributions to the Zhejiang Provincial Science and Technology Program in Traditional Chinese Medicine and Jiaxing City’s Science and Technology Program. Presently, she is leading three active research projects aimed at developing innovative therapeutic strategies and improving patient outcomes in chest oncology. Her studies demonstrate a strong commitment to integrating clinical experience with advanced research methodologies, paving the way for evidence-based, patient-centered cancer care.Dr. Xu’s scholarly impact is reflected in her extensive publication record in high-quality journals indexed in SCI and Scopus. Notable works include Development and Validation of a Prognostic Nomogram for Early Stage Non-Small Cell Lung Cancer: A Study Based on the SEER Database and a Chinese Cohort, Effect of Postoperative Radiotherapy on Survival in Patients with Completely Resected and Pathologically Confirmed Stage N2 Non-Small-Cell Lung Cancer: A Systematic Review and Meta-Analysis, LncRNA HCG11 Enhances the Chemosensitivity of Non-Small Cell Lung Cancer Cells to Gemcitabine via miR-17-5p/p21 Axis, and Akkermansia Muciniphila Outer Membrane Protein Regulates Recruitment of CD8+ T Cells in Lung Adenocarcinoma and Through JAK–STAT Signalling Pathway. These publications highlight her expertise in clinical oncology research, molecular biology, and the exploration of novel therapeutic targets.Her contributions to the academic community extend beyond research. Dr. Xu has been actively involved in professional organizations such as the Second Youth Committee of the Cancer Support Treatment Committee of the Zhejiang Society of Mathematical Medicine, the Chinese Society of Clinical Oncology’s expert committee on integrated traditional and Western medicine, and the Youth Committee of the Zhejiang Medical Association Oncology Branch. Through these roles, she fosters collaboration, knowledge-sharing, and the translation of research findings into clinical practice.

Profile: Scopus

Featured Publications

Authors Unknown. (2024). Akkermansia muciniphila outer membrane protein regulates recruitment of CD8+ T cells in lung adenocarcinoma and through JAK–STAT signalling pathway. Microbial Biotechnology.

Authors Unknown. (n.d.). Research progress in the therapeutic application of traditional Chinese medicine for postoperative cough in patients with lung cancer. Journal Name Unknown.

Authors Unknown. (n.d.). LncRNA HCG11 enhances the chemosensitivity of non-small cell lung cancer cells to Gemcitabine via miR-17-5p/p21 axis. Expert Review of Anticancer Therapy.

Shu-Rong Ban | Pharmaceutical Chemistry | Excellence in Research Award

Published on by Top Pharmaceutical

Prof. Shu-Rong Ban | Pharmaceutical Chemistry | Excellence in Research Award

Shanxi Medical University | China

Prof. Shu-Rong Ban is a distinguished scholar in the field of medicinal chemistry with a solid academic foundation and a long-standing commitment to research, teaching, and scientific innovation. He began his academic journey at Tianjin Normal University, where he obtained his bachelor’s degree, and later pursued a combined master’s and doctoral program at Nankai University, successfully earning his doctorate. His professional career has been deeply rooted in the School of Pharmacy at Shanxi Medical University, where he advanced through the ranks from lecturer to associate professor and later professor, reflecting his dedication and contributions to the field. He also enriched his academic perspective through international exposure as a visiting scholar at McGill University in Canada and at the Beijing Institute of Technology, experiences that expanded his research horizons and fostered collaborative ties with leading researchers worldwide.Prof. Ban has been actively involved in academic leadership and professional service. He holds memberships and leadership positions in multiple professional organizations, including serving as a member of the Pharmacy Education Professional Committee of the Chinese Pharmaceutical Association, director of the Shanxi Pharmaceutical Association, deputy director of its Academic Working Committee, and director of the Shanxi Chemical Society. His academic excellence has been recognized through honors such as the Shanxi Provincial Science and Technology Progress Award, the “Three Educations” Advanced Individual Award of Shanxi Medical University, and the Excellent Graduate Tutor distinction, reflecting both his research achievements and commitment to education.In teaching, Prof. Ban has played a key role in shaping pharmacy education, offering undergraduate courses such as Organic Chemistry, Organic Chemistry Experiment, and Professional English, as well as postgraduate courses including Progress in Pharmacy, Introduction to the Frontier of Medicinal Chemistry, and Pharmaceutical Preparation Technology. Notably, his course on Organic Chemistry was selected as a Shanxi Provincial First-Class Course, highlighting his innovation in teaching methodology and curriculum design.

Profile: Orcid

Featured Publications

Guo, L., Kang, S., Liu, J., Ma, Y., Tian, Y., Wang, B., Ma, S., Li, L., Yan, L., Zhang, C., & Liu, W., et al. (2024). Activatable near-infrared fluorescent/photoacoustic probe for rapid identification of β-lactam-resistant bacteria. Microchemical Journal.

Ge, R., Song, J., Cao, Z., Ban, S., Tang, L., & Li, Q. (2024). Discovery of 6-acylamino/sulfonamido benzoxazolone with IL-6 inhibitory activity as promising therapeutic agents for ulcerative colitis. Chemistry & Biodiversity.

Liu, J., Li, X., Xie, S., Ma, R., Wang, H., Ban, S., Zhang, C., & Guo, L. (2024). Fabricating a PDA-NOate@CuS coated NIR-activatable titanium implant to realize simultaneous antiinfection and osseointegration. New Journal of Chemistry.

Yao, J., Li, C., Feng, J., Wei, B., Xing, R., Ban, S., Tang, L., & Liu, B. (2024). Mn-doped CeO₂ nanorods for the colorimetric sensing of glutathione. ACS Applied Nano Materials.

Liu, Y., Fu, Z., Yang, C., Luo, M., Ban, S., & Wang, S. (2024). Rh(III)-catalyzed aminoalkylation of alkenes with diazo compounds toward functionalized isoindolinones. Chinese Journal of Organic Chemistry.

Meng, S., Cao, Z., Bai, H., Ge, R., Ban, S., Tang, L., & Li, Q. (2023). Antinociceptive action of 4-(5′-dimethylamino)-naphthalenesulfonyl-2(3H)-benzoxazolone (W3D) on animal models of pain via inhibitory effects on NO and iNOS. Natural Product Communications.

Li, G., Zhang, H., Zhang, G., Wei, B., Liu, B., Song, H., Li, Q., & Ban, S. (2023). Asymmetric synthesis of spiropyrazolone-fused dihydrofuran-naphthoquinones bearing contiguous stereocenters via a Michael addition/chlorination/nucleophilic substitution sequence. Journal of Organic Chemistry.

Dibyanshu | Pharmaceutical Analysis | Best Researcher Award

Published on by Top Pharmaceutical

Dr. Dibyanshu | Pharmaceutical Analysis | Best Researcher Award

Freiberg University of Mining and Technology | Germany

Dr. Dibyanshu is an accomplished researcher in the field of Environmental Engineering, with expertise spanning emerging contaminants, fate and transport mechanisms, colloid filtration, and groundwater remediation. He completed his doctoral studies at the prestigious Indian Institute of Technology, Patna, where his dissertation, Fate and Transport Behavior of Engineered Nanoparticles through Porous Media, contributed valuable insights into contaminant migration in subsurface environments. His academic journey includes an Integrated M-Tech in Water Engineering and Management from the Central University of Jharkhand, followed by a series of impactful research and teaching positions, including Assistant Professorship and Research Assistantship roles at leading institutions.As an Alexander von Humboldt post-doctoral fellow at Technische Universität Bergakademie Freiberg, Germany, Dr. Dibyanshu focuses on the Fate and Transport of Pharmaceuticals through Unsaturated Porous Media via Infiltration, emphasizing sustainable solutions for groundwater quality management. His earlier work on In-situ Remediation of Arsenic Using Immobilized Iron Sulphide in 3-D Tank Systems reflects his commitment to practical environmental applications alongside theoretical advancements.Dr. Dibyanshu’s research portfolio features an impressive array of peer-reviewed publications in high-impact journals. Notable works include Influence of Agricultural Practices and Environmental Conditions on Pharmaceuticals in Recharge Waters in Science of The Total Environment, Emerging Contaminants: Assessing the Release of Pharmaceuticals via Managed Aquifer Recharge in Environmental Science and Pollution Research, and Trace Compounds in the Urban Water Cycle in the Freiberg Region, Germany in Frontiers in Water. His contributions extend to modeling studies such as Modeling the Transport Behavior of Zinc Oxide Nanoparticles in Soil under Various Environmental Conditions in Water, Air, & Soil Pollution and comprehensive reviews like Fate and Transport Behavior of Engineered Nanoparticles

Profile: Google Scholar

Featured Publications

Dibyanshu, K., Chhaya, T., & Raychoudhury, T. (2023). A review on the fate and transport behavior of engineered nanoparticles: Possibility of becoming an emerging contaminant in the groundwater. International Journal of Environmental Science and Technology, 20(4), 4649–4672.

Dibyanshu, & Raychoudhury, T. (2019). Co-transport behavior of nano-ZnO particles in the presence of metal-nanoparticles through saturated porous media. Journal of Environmental Chemical Engineering, 7(3), 103103.

Dibyanshu, & Raychoudhury, T. (2020). Transport behaviour of different metal-based nanoparticles through natural sediment in the presence of humic acid and under the groundwater condition. Journal of Earth System Science, 129(1), 1–12.

Kumar, A., Dibyanshu, & Raychoudhury, T. (2020). Long-term fate of ZnO-FexOy mix-nanoparticles through the saturated porous media under constant head condition. Science of The Total Environment, 721, 137669.

Dibyanshu, Pradhan, I., Nayak, A., & Raychoudhury, T. (2021). Variation in porous media compositions influence the co-transport behavior of ZnO and FexOy mixed nanoparticles. Groundwater for Sustainable Development, 100710.

Chhaya, S., Dibyanshu, S., Singh, S., & Raychoudhury, T. (2022). Nanoparticles and nanocomposite materials for water treatment: Application in fixed bed column filter. In Sustainable Water Treatment: Advances and Technological Interventions (pp. 171–244).

Seetha, N., Dibyanshu, & Raychoudhury, T. (2024). Modeling the transport behavior of zinc oxide nanoparticles in soil under various environmental conditions. Water, Air, & Soil Pollution, 235(1), 55.

Dibyanshu, Kern, M., & Scheytt, T. (2024). Trace compounds in the urban water cycle in the Freiberg region, Germany. Frontiers in Water, 6, 1335766.